Hester Biosciences Ltd. may fall short of its Rs 140-145 crore internal sales target in the current fiscal, its Managing Director Rajiv Gandhi said.
Although the company expects its revenue to grow about 25 percent in the next fiscal, there might be a slight decline in the margins, Gandhi told BloombergQuint in an interview.
ADVERTISEMENT
ADVERTISEMENT